Worldwide Hematopoietic Stem Cell Transplantation Industry to 2027 - Featuring Pluristem Therapeutics, CellGenix and Regen Biopharma Among Others

News provided by

Aug 03, 2021, 07:15 ET

DUBLIN, Aug. 3, 2021 /PRNewswire/ -- The "Hematopoietic Stem Cell Transplantation (HSCT) Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.

Hematopoietic stem cell transplantation is a procedure in which multipotent hematopoietic stem cells sourced from peripheral blood cells, bone marrow, or umbilical cord blood are transplanted into the patient. Hematopoietic stem cell transplantation is commonly used in the treatment of lymphoma (Hodgkin, Non-Hodgkin), leukemia, multiple myeloma, thalassemia, sickle cell anemia, and osteoporosis. It includes two transplantation sources; 1) autologous, that uses stem cells from the patient's own body, 2) and allogeneic that sources stem cells from a donor's body. According to World Health Organization (WHO), over 50,000 hematopoietic stem cell transplantation procedures are carried out globally, every year and this number is expected to increase over the years.

Market Dynamics

The global hematopoietic stem cell transplantation market is expected to witness significant growth during the forecast period owing to the increasing prevalence of leukemia and lymphoma. According to Center for Disease Control and Prevention (CDC), in the U.S., around 45,360 people were diagnosed with leukemia in 2013, leading to 23,549 fatalities (13,625 men and 9,924 women). According to the same source the condition is more prevalent among men than women. Leukemia accounts for around 3% of all new cancer cases.

Key features of the study:

This report provides in-depth analysis of the global hematopoietic stem cell transplantation market, market size (US$ Mn), and compound annual growth rate (CAGR %) for the forecast period 2020-2027, considering 2019 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global hematopoietic stem cell transplantation market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study are Pluristem Therapeutics Inc., CellGenix GmbH, Regen Biopharma Inc., Lonza Group, Kiadis Pharma, Taiga Biotechnologies, Inc., Takeda Pharmaceutical Company Limited, Escape Therapeutics, Inc., Bluebird Bio, Talaris Therapeutics, Inc., Marker Therapeutics Inc., and Stempeutics Research Pvt Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
The global hematopoietic stem cell transplantation market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the hematopoietic stem cell transplantation market, research and consulting firms, new entrants, and financial analysts.

Key Topics Covered:

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Pipeline Analysis
PEST Analysis
Reimbursement Scenario
Regulatory Scenario
Epidemiology
Government Initiatives
Treatment Algorithm

4. Impact Analysis of COVID-19

COVID-19 Epidemiology
Guidelines for COVID-19 Management in Hematopoietic Stem Cell Transplantation (HSCT)
Impact of COVID-19 on Clinical Trials

5. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Transplant Type, 2016 - 2027, (US$ Million)

Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 - 2027
Segment Trends
Autologous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
Allogeneic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Indication, 2016 - 2027, (US$ Million)

Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 - 2027
Segment Trends
Acute Myeloid Leukemia (AML)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
Acute Lymphoblastic Leukemia (ALL)
Introduction
Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
Hodgkin lymphoma (HL)
Introduction
Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
Non-Hodgkin Lymphoma (NHL)
Introduction
Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
Multiple Myeloma (MM)
Introduction
Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
Other Non-malignant Disorders
Introduction
Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Application, 2016 - 2027, (US$ Million)

Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 - 2027
Segment Trends
Bone Marrow Transplant (BMT)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
Peripheral Blood Stem Cells Transplant (PBSCT)
Introduction
Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
Cord Blood Transplant (CBT)
Introduction
Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

8. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Region, 2016 - 2027, (US$ Million)

Introduction
Market Share Analysis, By Region, 2020 and 2027 (%)
Y-o-Y Growth Analysis, By Region, 2017 - 2027
Regional Trends
North America
Market Size and Forecast, By Transplant Type, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Transplant Type, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Latin America
Market Size and Forecast, By Transplant Type, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Asia Pacific
Market Size and Forecast, By Transplant Type, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Transplant Type, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Transplant Type, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
Pluristem Therapeutics Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
CellGenix GmbH
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Regen Biopharma Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Lonza Group
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Kiadis Pharma
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Taiga Biotechnologies, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Takeda Pharmaceutical Company Limited
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Escape Therapeutics, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Bluebird Bio
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Talaris Therapeutics, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Marker Therapeutics Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Stempeutics Research Pvt Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

10. Section

References
Research Methodology
About us and Sales Contact

For more information about this report visit https://www.researchandmarkets.com/r/lezsmn

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets